4.1 Article

Treatment of Vascular and Neurodegenerative Forms of Cognitive Impairment and Dementias

Related references

Note: Only part of the references are listed.
Article Geriatrics & Gerontology

Firearm access and dementia: A qualitative study of reported behavioral disturbances and responses

Evan R. Polzer et al.

Summary: The study highlights the behavioral disruptions and emotional burdens faced by ADRD caregivers regarding firearm access, but also suggests strategies for restricting or safeguarding firearms in the home.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2022)

Article Clinical Neurology

AD and its comorbidities: An obstacle to develop a clinically efficient treatment?

J. Baker et al.

REVUE NEUROLOGIQUE (2022)

Review Geriatrics & Gerontology

Past, Present, and Future of Non-invasive Brain Stimulation Approaches to Treat Cognitive Impairment in Neurodegenerative Diseases: Time for a Comprehensive Critical Review

Clara Sanches et al.

Summary: Research has shown that non-invasive brain stimulation (NIBS) may help limit cognitive decline associated with neurodegenerative conditions, but the current clinical evidence is not yet sufficient to demonstrate its therapeutic benefit and clinical significance. Therefore, more double-blind placebo-controlled randomized clinical trials and reliable biomarkers are needed to strengthen the research.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Review Clinical Neurology

Driving and Alzheimer's dementia or mild cognitive impairment: a systematic review of the existing guidelines emphasizing on the neurologist's role

Petros Stamatelos et al.

Summary: Driving is a complex task that requires the integrity and cooperation of cognition, motor, and somatosensory skills, all impacted by neurological diseases. Neurologists play a critical role in assessing the fitness to drive of cognitively impaired individuals. Research indicates that, despite numerous guidelines and recommendations, there is still no widely accepted approach for evaluating the driving ability of cognitively impaired individuals.

NEUROLOGICAL SCIENCES (2021)

Article Neurosciences

Mild Behavioral Impairment and Subjective Cognitive Decline Predict Cognitive and Functional Decline

Zahinoor Ismail et al.

Summary: The study showed that individuals with both MBI and SCD had the highest risk of cognitive and functional decline, suggesting that these two conditions combined can serve as a simple and scalable method to identify high-risk patients.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Article Neurosciences

Biting the Bullet: Firearm Ownership in Persons with Dementia. A Registry-Based Observational Study

Emilia Schwertner et al.

Summary: Firearm ownership among persons with dementia in Sweden is more common in younger males who live independently. The decision to report someone as unsuitable to possess a firearm is influenced by factors such as living with others, frontotemporal dementia, and antipsychotic medication use.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Review Geriatrics & Gerontology

Fall prevention in community-dwelling adults with mild to moderate cognitive impairment: a systematic review and meta-analysis

M. Racey et al.

Summary: This study reviewed fall prevention interventions in community-dwelling older adults with mild to moderate cognitive impairment, finding that exercise interventions are effective in improving balance and fear of falling but the direct impact on reducing falls is still unclear. There is a gap in effective fall prevention interventions for older adults with cognitive impairment, indicating a need for further research in this area.

BMC GERIATRICS (2021)

Article Clinical Neurology

Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality

Hong Xu et al.

Summary: The study showed that ChEIs are associated with a slower cognitive decline in Alzheimer's disease patients as well as a decreased risk of severe dementia or death. Galantamine was particularly effective in reducing mortality and the risk of severe dementia, while all ChEIs had a modest but persistent effect on cognitive benefits over time.

NEUROLOGY (2021)

Review Clinical Neurology

Critical Appraisal of Amyloid Lowering Agents in AD

Boris Decourt et al.

Summary: According to the amyloid cascade hypothesis, removing amyloid beta (A beta) is believed to cure Alzheimer's disease (AD), but current clinical trials lack definitive efficacy. Therefore, research has shifted focus towards immunotherapy, particularly monoclonal antibody therapies targeting A beta plaques. This approach offers potential for treating different stages of AD and may provide valuable insights into the trajectory of drug development for neurodegenerative diseases.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2021)

Editorial Material Clinical Neurology

A resurrection of aducanumab for Alzheimer's disease

Lon Schneider

LANCET NEUROLOGY (2020)

Article Clinical Neurology

Recommendation of the 5th Canadian Consensus Conference on the diagnosis and treatment of dementia

Zahinoor Ismail et al.

ALZHEIMERS & DEMENTIA (2020)

Review Nursing

Advance care planning for people living with dementia: An umbrella review of effectiveness and experiences

Annelien Wendrich-van Dael et al.

INTERNATIONAL JOURNAL OF NURSING STUDIES (2020)

Article Clinical Neurology

Canadian Consensus Conference on Diagnosis and Treatment of Dementia (CCCDTD)5: Guidelines for management of vascular cognitive impairment

Eric E. Smith et al.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2020)

Article Clinical Neurology

Safety, pharmacokinetics, and pharmacodynamics of Gln-1062, a prodrug of galantamine

Charlotte Bakker et al.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2020)

Article Geriatrics & Gerontology

American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults

Donna M. Fick et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2019)

Review Pharmacology & Pharmacy

Neuropsychiatric Symptoms in Dementia: Considerations for Pharmacotherapy in the USA

Stephanie V. Phan et al.

DRUGS IN R&D (2019)

Review Geriatrics & Gerontology

Review of Gait, Cognition, and Fall Risks with Implications for Fall Prevention in Older Adults with Dementia

Weihong Zhang et al.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2019)

Article Geriatrics & Gerontology

New horizons in falls prevention

Stephen R. Lord et al.

AGE AND AGEING (2018)

Article Pharmacology & Pharmacy

Galantamine is not a positive allosteric modulator of human alpha 4 beta 2 or alpha 7 nicotinic acetylcholine receptors

Natalia M. Kowal et al.

BRITISH JOURNAL OF PHARMACOLOGY (2018)

Article Medicine, General & Internal

Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease

Lawrence S. Honig et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Audiology & Speech-Language Pathology

Speech-Language Pathologist Interventions for Communication in Moderate-Severe Dementia: A Systematic Review

Katina Swan et al.

AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY (2018)

Review Neurosciences

A review of clinical treatment considerations of donepezil in severe Alzheimer's disease

Aida Adlimoghaddam et al.

CNS NEUROSCIENCE & THERAPEUTICS (2018)

Article Pharmacology & Pharmacy

The efficacy and safety of memantine for the treatment of Alzheimer's disease

Shinji Matsunaga et al.

EXPERT OPINION ON DRUG SAFETY (2018)

Review Pharmacology & Pharmacy

An update on the safety of current therapies for Alzheimer's disease: focus on rivastigmine

Rita Khoury et al.

THERAPEUTIC ADVANCES IN DRUG SAFETY (2018)

Article Geriatrics & Gerontology

Adherence and Tolerability of Alzheimer's Disease Medications: A Pragmatic Randomized Trial

Noll L. Campbell et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2017)

Review Psychiatry

Dementia Caregiver Burden: a Research Update and Critical Analysis

Sheung-Tak Cheng

CURRENT PSYCHIATRY REPORTS (2017)

Article Clinical Neurology

A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease

Susanne Ostrowitzki et al.

ALZHEIMERS RESEARCH & THERAPY (2017)

Article Clinical Neurology

Cholinesterase Inhibitors for Lewy Body Disorders: A Meta-Analysis

Shinji Matsunaga et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)

Review Geriatrics & Gerontology

Person-centered dementia care: current perspectives

Jill Manthorpe et al.

CLINICAL INTERVENTIONS IN AGING (2016)

Review Clinical Neurology

Donepezil across the spectrum of Alzheimer's disease: dose optimization and clinical relevance

J. -H. Lee et al.

ACTA NEUROLOGICA SCANDINAVICA (2015)

Article Neurosciences

Physiotherapy Intervention in Alzheimer's Disease: Systematic Review and Meta-Analysis

Xi-Chen Zhu et al.

JOURNAL OF ALZHEIMERS DISEASE (2015)

Review Medicine, General & Internal

The overlap between vascular disease and Alzheimer's disease - lessons from pathology

Johannes Attems et al.

BMC MEDICINE (2014)

Article Geriatrics & Gerontology

Is There a Gun in the Home? Assessing the Risks of Gun Ownership in Older Adults

Ellen M. Pinholt et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2014)

Review Geriatrics & Gerontology

Wandering and dementia

Gabriele Cipriani et al.

PSYCHOGERIATRICS (2014)

Review Clinical Neurology

Treating Alzheimer's disease with monoclonal antibodies: current status and outlook for the future

Niels D. Prins et al.

ALZHEIMERS RESEARCH & THERAPY (2013)

Article Geriatrics & Gerontology

Gait and Cognition: A Complementary Approach to Understanding Brain Function and the Risk of Falling

Manuel Montero-Odasso et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2012)

Article Geriatrics & Gerontology

Caregiver support groups in patients with dementia: a meta-analysis

Ling-Yu Chien et al.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2011)

Review Psychology, Clinical

Switching cholinesterase inhibitors in older adults with dementia

Fadi Massoud et al.

INTERNATIONAL PSYCHOGERIATRICS (2011)

Article Neurosciences

Far transfer in cognitive training of older adults

Elizabeth M. Zelinski

RESTORATIVE NEUROLOGY AND NEUROSCIENCE (2009)

Review Medicine, General & Internal

Driving and dementia

David A. Breen et al.

BMJ-BRITISH MEDICAL JOURNAL (2007)

Review Medicine, General & Internal

Risk of death with atypical antipsychotic drug treatment for dementia - Meta-analysis of randomized placebo-controlled trials

LS Schneider et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)

Article Psychiatry

The consequences of non-cognitive symptoms of dementia in medical hospital departments

J Wancata et al.

INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE (2003)

Article Pharmacology & Pharmacy

A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500)

G Wilcock et al.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2002)

Article Medicine, General & Internal

Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment - Results from the Cardiovascular Health Study

CG Lyketsos et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)